{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:15:30Z","timestamp":1788909330536,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cirug\u00eda Espa\u00f1ola"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ciresp.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T14:59:34Z","timestamp":1533308374000},"page":"560-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Complicaciones de la quimioembolizaci\u00f3n transarterial (QETA) en el tratamiento de los tumores hep\u00e1ticos"],"prefix":"10.1016","volume":"96","author":[{"given":"Alberto","family":"Marcacuzco Quinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana-Anisa","family":"Nutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"San Rom\u00e1n Manso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iago","family":"Justo Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Calvo Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Manrique Municio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Garc\u00eda-Sesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmelo","family":"Loinaz Segurola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00ednez Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Carlos","family":"Jim\u00e9nez Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ciresp.2018.06.004_bib0180","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1053\/j.gastro.2004.09.036","article-title":"Hepatocellular carcinoma: Current management and future trends","volume":"127","author":"Carr","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0185","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","article-title":"Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)","volume":"24","author":"Kemeny","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00001622-199901000-00009","article-title":"Embolization and chemoembolization therapy for neuroendocrine tumors","volume":"11","author":"Venook","year":"1999","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000367739","article-title":"Surgical and locoregional therapy of HCC: TACE","volume":"4","author":"Tsurusaki","year":"2015","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0200","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/1097-0142(20000915)89:6<1236::AID-CNCR7>3.0.CO;2-K","article-title":"Correlation between angiographically assessed vascularity and blood flow in hepatic metastases in patients with colorectal carcinoma","volume":"89","author":"Yamaguchi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0205","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jso.21522","article-title":"Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)","volume":"101","author":"Dhanasekaran","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicineluting-bead embolization in the treatment of hepatocellular carcinoma: Results of the PRECISIONV study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0215","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0220","first-page":"239","article-title":"Adverse events following transarterial chemoembolization for hepatocellular carcinoma and factors predicting such events","volume":"6","author":"Tasneem","year":"2013","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4321\/S1130-01082014000200014","article-title":"Acute necrotizing pancreatitis after transarterial chemoembolization of hepatocellular carcinoma: An unusual complication","volume":"106","author":"Alc\u00edvar-V\u00e1squez","year":"2014","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0230","doi-asserted-by":"crossref","first-page":"e3987","DOI":"10.1097\/MD.0000000000003987","article-title":"Duodenal perforation and esophageal ischemia following transarterial chemoembolization for hepatocellular carcinoma","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0235","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0240","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0245","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0250","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocelullar carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0255","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.ejrad.2012.12.009","article-title":"Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants","volume":"82","author":"Bargellini","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0260","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v5.0, 2017 [consultado 28 Abr 2018]. Disponible en: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/.ctc.htm"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0265","first-page":"593","article-title":"Hepatic, arterial embolization in patients with malignant liver tumours","volume":"17","author":"Doyon","year":"1974","journal-title":"Ann Radiol (Paris)"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0270","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1148\/radiology.148.2.6306721","article-title":"Hepatic artery embolization in 120 patients with unresectable hepatoma","volume":"148","author":"Yamada","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0275","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1097-0142(19901101)66:9<1897::AID-CNCR2820660907>3.0.CO;2-J","article-title":"Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium","volume":"66","author":"Konno","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0280","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1478-3231.2009.02166.x","article-title":"Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma","volume":"30","author":"Chua","year":"2010","journal-title":"Liver Int."},{"key":"10.1016\/j.ciresp.2018.06.004_bib0285","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1665-2681(19)30839-7","article-title":"What is changing in indications and treatment of hepatic hemangiomas. A review","volume":"13","author":"Toro","year":"2014","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0290","doi-asserted-by":"crossref","first-page":"471203","DOI":"10.1155\/2012\/471203","article-title":"Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors","volume":"2012","author":"Lee","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0295","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1051-0443(07)61911-3","article-title":"Determinants of postembolization syndrome after hepatic chemoembolization","volume":"12","author":"Leung","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0300","doi-asserted-by":"crossref","first-page":"e5606","DOI":"10.1097\/MD.0000000000005606","article-title":"The incidence and outcome of major complications following conventional TAE\/TACE for hepatocellular carcinoma","volume":"95","author":"Tu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0305","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4329\/wjr.v4.i9.405","article-title":"Embolization of liver tumors: Past, present and future","volume":"4","author":"Rammohan","year":"2012","journal-title":"World J Radiol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0310","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1053\/j.gastro.2004.09.032","article-title":"Chemoembolization for hepatocellular carcinoma","volume":"127","author":"Bruix","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0315","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.diii.2015.06.017","article-title":"Biliary complications of arterial chemoembolization of hepatocellular carcinoma","volume":"96","author":"Dhamija","year":"2015","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0320","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00330-016-4488-y","article-title":"Liver and biliary damages following transarteril chemoembolization of hepatocellular carcinoma: Comparison between drug eluting beads and lipiodol emulsion","volume":"27","author":"Monier","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0325","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.medcli.2017.02.005","article-title":"Acute necrotizing pancreatitis after transarterial chemoembolization in candidates for a liver transplant","volume":"149","author":"Nutu","year":"2017","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0330","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1499-3872(15)60034-0","article-title":"Acute pancreatitis induced by transarterial chemoembolization: A single-center experience of over 1500 cases","volume":"15","author":"She","year":"2016","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0335","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1365-2036.2004.01936.x","article-title":"Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: A retrospective study of the incidence, risk factors, clinical course and long-term outcome","volume":"19","author":"Huo","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0340","doi-asserted-by":"crossref","first-page":"e3503","DOI":"10.1097\/MD.0000000000003503","article-title":"Liver abscess formation following transarterial chemoebolization","volume":"95","author":"Lv","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0345","first-page":"1158","article-title":"Management of pyogenic liver abscesses \u2014 percutaneous or open drainage?","volume":"48","author":"Chung","year":"2007","journal-title":"Singapore Med J"},{"key":"10.1016\/j.ciresp.2018.06.004_bib0350","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5320\/wjr.v6.i3.69","article-title":"Pulmonary complications of transcatheter arterial chemoembolization for hepatocellular carcinoma","volume":"6","author":"Nhu","year":"2016","journal-title":"World J Respirol"}],"container-title":["Cirug\u00eda Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009739X18301726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009739X18301726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T07:55:57Z","timestamp":1604735757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009739X18301726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0009739X18301726"],"URL":"https:\/\/doi.org\/10.1016\/j.ciresp.2018.06.004","relation":{},"ISSN":["0009-739X"],"issn-type":[{"value":"0009-739X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complicaciones de la quimioembolizaci\u00f3n transarterial (QETA) en el tratamiento de los tumores hep\u00e1ticos","name":"articletitle","label":"Article Title"},{"value":"Cirug\u00eda Espa\u00f1ola","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ciresp.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 AEC. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}